BaseHealth is a technology company.
BaseHealth has raised $4.0M across 2 funding rounds.
BaseHealth has raised $4.0M in total across 2 funding rounds.
BaseHealth has raised $4.0M in total across 2 funding rounds.
BaseHealth's investors include Think + Ventures, TSVC Capital, Ulu Ventures.
BaseHealth is a healthcare analytics company that develops a proprietary machine learning and AI platform to help health systems and Medicare Advantage (MA) plans optimize revenues, cost-savings, and clinical outcomes.[1][3] It serves healthcare organizations (HCOs) and MA plans by analyzing laboratory data, claims, and clinical research to predict patient health risks prospectively, without relying on retrospective claims or ICD codes, enabling proactive interventions and risk adjustment.[1][3] The platform addresses population health management challenges, particularly for MA plans with capitated payments and new members lacking historical data, improving RAF scores and value-based care.[3]
BaseHealth demonstrates growth through milestones like launching its predictive platform in 2018 and raising $8.5M in Series C funding led by HBM Healthcare Investments to expand analytics development.[1]
Founded by Hossein Fakhrai-Rad, PhD, as President, BaseHealth emerged in Sunnyvale, California, focusing on predictive health analytics using patient laboratory data to uncover hidden risks.[1][3] The idea stemmed from recognizing limitations in traditional claims-based systems, leading to the 2018 launch of the first platform mining lab data with machine learning for proactive risk identification and interventions.[3] Early traction included partnerships, such as with Executive Health Centre in 2016 for genomics-driven predictive models and Banner Health for precision insights in population health.[5][6] Funding momentum built with an $8.5M Series C round, supporting platform evolution.[1]
BaseHealth rides the wave of AI-driven precision medicine and value-based care trends, where shifting from reactive claims to predictive lab-based analytics aligns with rising MA enrollment and capitated payment pressures.[3] Timing is key amid healthcare's data explosion—lab results offer real-time signals traditional methods miss—fueled by market forces like Medicare risk adjustment needs and HCO demands for cost control.[1][3] It influences the ecosystem by pioneering lab-AI integration, enabling providers to proactively manage chronic risks, reduce high-cost events, and support scalable population health in a post-claims era.[3][6]
BaseHealth is poised to expand its platform amid surging AI health analytics adoption, potentially deepening MA and HCO integrations for broader risk prediction. Trends like multimodal data fusion (labs + genomics) and regulatory pushes for outcome-based payments will propel growth, evolving its role from niche predictor to ecosystem standard.[1][3][5] As precision health scales, BaseHealth's lab-first edge could amplify revenues and outcomes, redefining proactive care from the outset.
BaseHealth has raised $4.0M across 2 funding rounds. Most recently, it raised $2.0M Venture Round in May 2012.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| May 1, 2012 | $2.0M Venture Round | Think + Ventures, TSVC Capital, Ulu Ventures | |
| May 1, 2011 | $2.0M Series A | Think + Ventures, TSVC Capital, Ulu Ventures |